Skip to main content

Table 2 Association of IGT with the components of metabolic syndrome a

From: Metabolic syndrome and the early detection of impaired glucose tolerance among professionals living in Beijing, China: a cross sectional study

 

Prevalence (%)

Number of IGT (%)

OR (95% CI)

AROC (95% CI)

AR %

PAR %

MS-NCEP

309 (33.3)

129 (41.8)

3.16 (2.26-4.42)

63.4 (60.3-66.5)

64.0

37.2

MS-IDF

278 (30.0)

132 (42.1)

2.84 (2.03-3.97)

63.0 (60.0 -66.0)

61.6

32.5

Central obesity

489 (52.7)

158 (32.3)

2.06 (1.46-2.91)

58.9 (56.2-61.5)

54.9

39.1

Hyperglycemia

279 (30.1)

118 (42.3)

2.79 (1.99-3.91)

66.9 (61.5-72.3)

61.3

32.6

High TG

293 (31.6)

96 (32.8)

1.95 (1.39-2.74)

56.5 (53.4-59.6)

39.4

17.1

Low HDL-C

301 (32.4)

91 (30.2)

1.65 (1.19-2.30)

54.7 (51.6-57.7)

30.9

12.7

High BP

415 (44.7)

141 (34.0)

1.61 (1.13-2.30)

59.1 (56.3-62.9)

53.5

34.0

  1. aLogistic regression was age-and gender-adjusted. IGT: impaired glucose tolerance; MS: metabolic syndrome; NCEP: National Cholesterol Education Program; IDF: International Diabetes Federation; TG: triglycerides; HDL-C: high-density-lipoprotein cholesterol; BP: blood pressure; AROC: receiver-operating characteristic curve; AR %: Attributable risk percentage; PAR %: Population attributable risk percentage.